Apoptosis, vascularity, and proliferation in primary central nervous system lymphomas (PCNSL): A histopathological study

Surgical Neurology

Volumn 62, Issue 5, 2004, Pages 393-399

  Roser, Florian ^a,d   Saini, Marco ^a   Meliss, Rainer ^b   Ostertag, Helmut ^b   Samii, Madjid ^c   Bellinzona, Mattia ^a  

^a NORDSTADT HOSPITAL   (Germany)

^b Institute of Pathology   (Germany)

^c INTERNATIONAL NEUROSCIENCE INSTITUTE   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

apoptosis; brain; Ki 67; Lymphoma; vascularity

Indexed keywords

ADULT; AGED; APOPTOSIS; BLOOD VESSEL; CLASSIFICATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DENSITY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLAST; LABELING INDEX; MALE; NICK END LABELING; NONHODGKIN LYMPHOMA; REVIEW; STAINING; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; VASCULARIZATION;

EID: 7044240933     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2003.11.038     Document Type: Article

References (36)

1. Abrey L.E., DeAngelis L.M., Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol. 16:1998;859-863
2. Assimakopoulou M., Sotiropoulou-Bonikou G., Maraziotis T., Papadakis N., Varakis I. Microvessel density in brain tumors. Anticancer Res. 17:1997;4747-4753
3. Barth T.F., Leithauser F., Dohner H., et al. Primary gastric apoptosis-rich T-cell lymphoma co-expressing CD4, CD8, and cytotoxic molecules. Virchows Arch. 436:2000;357-364
4. Bataille B., Delwail V., Menet E., et al. Primary intracerebral malignant lymphoma report of 248 cases. J Neurosurg. 92:2000;261-266
5. Bergmann M., Blasius S., Bankfalvi A., Mellin W. Primary non-Hodgkin lymphomas of the CNS-proliferation, oncoproteins and Epstein-Barr-virus. Gen Diagn Pathol. 141:1996;235-242
6. Bragg D.G. Radiographic findings in 32 cases of primary CNS lymphoma. Invest Radiol. 21:1986;826-827
7. Camilleri-Broet S., Martin A., Moreau A., et al. Primary central nervous system lymphomas in 72 immunocompetent patients pathologic findings and clinical correlations. Groupe Ouest Est d'etude des Leucenies et Autres Maladies du Sang (GOELAMS). Am J Clin Pathol. 110:1998;607-612
8. Chamberlain M.C. Primary CNS lymphoma. Neurology. 45:1995;1031-1032
9. Christov C., Adle-Biassette H., Lechapt E., et al. Primary brain lymphoma cell turnover differs in patients with and without AIDS relationships to bcl-2 expression and host cell reaction. J Neuropathol Exp Neurol. 58:1999;1069-1077
10. DeAngelis L.M. Primary CNS lymphoma treatment with combined chemotherapy and radiotherapy. J Neurooncol. 43:1999;249-257
11. DeAngelis L.M., Yahalom J., Heinemann M.H., Cirrincione C., Thaler H.T., Krol G. Primary CNS lymphoma combined treatment with chemotherapy and radiotherapy. Neurology. 40:1990;80-86
12. DeAngelis L.M., Yahalom J., Rosenblum M., Posner J.B. Primary CNS lymphoma managing patients with spontaneous and AIDS- related disease. Oncology (Huntingt). 1:1987;52-62
13. Deckert-Schlüter M., Rang A., Wiestler O.D. Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system. Acta Neuropathol (Berl). 96:1998;157-162
14. Deckert M., Reifenberger G., Wechsler W. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol. 115:1989;179-188
15. Eilber F.C., Rosen G., Forscher C., Nelson S.D., Dorey F.J., Eilber F.R. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas [see comments]. Ann Surg Oncol. 6:1999;645-650
16. Enestrom S., Vavruch L., Franlund B., Nordenskjold B. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas. Neurochirurgie. 44:1998;25-30
17. Evans-Storms R.B., Cidlowski J.A. Regulation of apoptosis by steroid hormones. J Steroid Biochem Mol Biol. 53:1995;1-8
18. Ferraresi S., Prosetti D., Griffini C., et al. Unusual radiological presentation of a primary CNS lymphoma. Ital J Neurol Sci. 10:1989;583-586
19. Grant J.W., Gallagher P.J., Jones D.B. Primary cerebral lymphoma. A histologic and immunohistochemical study of six cases. Arch Pathol Lab Med. 110:1986;897-901
20. Hao D., DiFrancesco L.M., Brasher P.M., et al. Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996. Ann Oncol. 10:1999;65-70
21. Herrlinger U., Schabet M., Clemens M., et al. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand. 97:1998;257-264
22. Iwata M. Regulation of apoptosis via steroid receptors. Curr Top Microbiol Immunol. 200:1995;81-94
23. Maher E.A., Fine H.A. Primary CNS lymphoma. Semin Oncol. 26:1999;346-356
24. Mead G.M., Bleehen N.M., Gregor A., et al. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer. 89:2000;1359-1370
25. Mennel H.D., Rossberg C., Lorenz H., Schneider H., Hellwig D. Reliability of simple cytological methods in brain tumour biopsy diagnosis. Neurochirurgia (Stuttg). 32:1989;129-134
26. Migheli A., Cavalla P., Marino S., Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol. 53:1994;606-616
27. Miller D.C., Hochberg F.H., Harris N.L., Gruber M.L., Louis D.N., Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer. 74:1994;1383-1397
28. Nakasu S., Li D.H., Okabe H., Nakajima M., Matsuda M. Significance of MIB-1 staining indices in meningiomas comparison of two counting methods. Am J Surg Pathol. 25:2001;472-478
29. Robbins P.D., Yu L.L., Lee M., et al. Stereotactic biopsy of 100 intracerebral lesions at Sir Charles Gairdner Hospital. Pathology. 26:1994;410-413
30. Roy G., Lombardia M., Palacios C., et al. Mechanistic aspects of the induction of apoptosis by lauryl gallate in the murine B-cell lymphoma line Wehi 231. Arch Biochem Biophys. 383:2000;206-214
31. Sanz M.A., Martin G., Rayon C., et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Blood. 94:1999;3015-3021
32. Schlegel U., Schmidt-Wolf I.G., Deckert M. Primary CNS lymphoma clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci. 181:2000;1-12
33. Sinha P., Hutter G., Kottgen E., Dietel M., Schadendorf D., Lage H. Search for novel proteins involved in the development of chemoresistance in colorectal cancer and fibrosarcoma cells in vitro using two-dimensional electrophoresis, mass spectrometry and microsequencing. Electrophoresis. 20:1999;2961-2969
34. Sonstein W., Tabaddor K., Llena J.F. Solitary primary CNS lymphoma long term survival following total resection. Med Oncol. 15:1998;61-65
35. Tomlinson F.H., Kurtin P.J., Suman V.J., et al. Primary intracerebral malignant lymphoma a clinicopathological study of 89 patients. J Neurosurg. 82:1995;558-566
36. Zimmer C., Marzheuser S., Patt S., et al. Stereotactic brain biopsy in AIDS. J Neurol. 239:1992;394-400